RERG gene expression is stimulated by both estrogen receptor (ER) α [29] and ERβ1 [31, 32], and it has been reported as a marker for ERα-positive luminal-like breast cancer and is associated with better clinical outcomes [33] or a favorable response to adjuvant tamoxifen treatment [34]. The gene discussed is RERG; the disease is breast carcinoma.